You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Encorafenib

Showing 1 - 25 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in New Haven (Encorafenib capsule formulation (CAP), Encorafenib first formulation, Encorafenib second

Completed
  • Healthy
  • Encorafenib capsule formulation (CAP)
  • +3 more
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Nov 2, 2022

ive is Encorafenib Plus Binimetinib in Real-world and Clinical

Not yet recruiting
  • Metastatic Melanoma
  • (no location specified)
Jul 12, 2023

Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2023

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

    Not yet recruiting
    • Colorectal Cancer
    • BRAF V600E Mutation Positive
    • Encorafenib Oral Capsule + Cetuximab
    • (no location specified)
    Jan 30, 2023

    Metastatic Colorectal Cancer Trial (ZN-c3, Encorafenib, Cetuximab)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • (no location specified)
    Feb 15, 2023

    Solid Tumor Trial in Toronto (Binimetinib, Encorafenib)

    Recruiting
    • Solid Tumor
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Sep 23, 2022

    Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

    Recruiting
    • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
    • +2 more
    • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
    • Chicago, Illinois
      Northwestern University
    Nov 16, 2022

    Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

    Not yet recruiting
    • Colorectal Cancer
    • +4 more
    • (no location specified)
    Aug 18, 2022

    Associated Factors, and Clinical Outcomes of Prescribing

    Completed
    • BRAF v600 Mutated Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis Pharmaceuticals
      Mar 28, 2023

      Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

      Recruiting
      • Clinical Stage IV Cutaneous Melanoma AJCC v8
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 9, 2022

      Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

      Not yet recruiting
      • Metastatic Colorectal Adenocarcinoma
      • +2 more
      • BET Bromodomain Inhibitor ZEN-3694
      • +6 more
      • (no location specified)
      Oct 25, 2023

      Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)

      Recruiting
      • Melanoma Stage III
      • +2 more
      • Encorafenib Pill
      • +2 more
      • Tampa, Florida
        Moffitt Cancer Center
      May 27, 2022

      Melanoma Trial in Worldwide (encorafenib, binimetinib, pembrolizumab)

      Recruiting
      • Melanoma
      • encorafenib
      • +4 more
      • Siena, Toscana, Italy
      • +11 more
      Jun 23, 2023

      Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,

      Not yet recruiting
      • Colon Adenocarcinoma
      • +4 more
      • Encorafenib
      • +5 more
      • (no location specified)
      Jan 24, 2023

      BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

      Recruiting
      • BRAF NP_004324.2:p.V600M
      • +6 more
      • Portland, Oregon
        Providence Portland Medical Center
      Aug 17, 2022

      BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)

      Completed
      • BRAF V600E Unresectable or Metastatic Melanoma
      • +2 more
      • Encorafenib
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jun 9, 2022

      Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

      Active, not recruiting
      • Metastatic Malignant Neoplasm in the Brain
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

      Terminated
      • Metastatic Colon Adenocarcinoma
      • +27 more
      • San Francisco, California
      • +1 more
      Jan 5, 2023

      Malignant Melanoma, BRAF V600 Mutation, Brain Metastases Trial in France (Stereotaxic radiosurgery (SRS), Binimetinib Oral

      Recruiting
      • Malignant Melanoma
      • +2 more
      • Stereotaxic radiosurgery (SRS)
      • +3 more
      • Bobigny, France
      • +20 more
      Oct 7, 2022

      Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)

      Recruiting
      • Melanoma Stage III
      • In-Transit Metastasis of Cutaneous Melanoma
      • Encorafenib + Binimetinib
      • Leiden, Zuid-Holland, Netherlands
        Leiden University Medical Center
      Mar 2, 2023

      Melanoma Trial in Pittsburgh (encorafenib, nivolumab, ipilimumab)

      Recruiting
      • Melanoma
      • encorafenib
      • +3 more
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Mar 24, 2022

      BRAF V600 Mutation, Unresectable Melanoma, Metastatic Melanoma Trial in Czechia, Italy, Spain (Encorafenib + Binimetinib)

      Not yet recruiting
      • BRAF V600 Mutation
      • +3 more
      • Encorafenib + Binimetinib
      • Olomouc, Czechia
      • +5 more
      Sep 14, 2021

      Colorectal Cancer, GIST Trial (DCC-3116, Ripretinib, Cetuximab)

      Not yet recruiting
      • Colorectal Cancer
      • GIST
      • (no location specified)
      Jul 14, 2023

      Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

      Recruiting
      • Cancer
      • Melbourne, Victoria, Australia
        Peter MacCallum Cancer Centre
      Nov 4, 2022